The dual roles of key cytokines such as TNF-α, TGF-β, IL-6, and IL-10, which act as both tumor suppressors and promoters depending on the tumor context, highlight the complexity of targeting these pathways therapeutically. This evidence concerns the gene IL10 and neoplasm.